Press Resease

Polymerase Chain Reaction (PCR) Market by Product (Instruments, Reagents and Consumables and Software) and End User: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

Published Date: 26-Mar-2018 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-2720 Status : Published

Global polymerase chain reaction market expected to reach USD 10.62 billion by the end of 2023, growing at a CAGR of around 6.2% between 2017 and 2023. The polymerase chain reaction market is segmented on the basis of product into instruments, reagents and consumables and software.

Description

The report covers forecast and analysis for the polymerase chain reaction market on a global and regional level. The study provides historic data of 2015 to 2017 along with a forecast from 2018 to 2023 based on revenue (USD Billion). The study includes drivers and restraints for the polymerase chain reaction market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the polymerase chain reaction market on a global level.

In order to give the users of this report a comprehensive view on the polymerase chain reaction market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market. 

Global Polymerase Chain Reaction Market

The study provides a decisive view on the polymerase chain reaction market by segmenting the market based on products, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023. Based on product, the market is segmented into instruments, reagents and consumables and software. Based on the end user, the market is segregated into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals and academic and research organization. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S., U.K., Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for polymerase chain reaction market based on technology in all the regions and countries.

The report also includes detailed profiles of end players such as Affymetrix, Inc., Agilent Technologies, Inc., Sigma Aldrich Corporation, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, QIAGEN, Becton Dickinson & Company and Thermo Fischer Scientific.

This report segments the global polymerase chain reaction market as follows:

Global Polymerase Chain Reaction Market: Product Segment Analysis

  • Instruments 
    • Standard PCR Systems
    • Real-Time PCR Systems
    • Digital PCR Systems
  • Reagents and Consumables
  • Software

Global Polymerase Chain Reaction Market: End-User Segment Analysis

  • Pharmaceutical and Biotechnology Industries
  • Clinical Diagnostics Labs and Hospitals
  • Academics and Research Organization

Global Polymerase Chain Reaction Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Polymerase Chain Reaction Market, 2015 – 2023 (USD Billion)
    • 2.2. Global Polymerase Chain Reaction Market: Snapshot
  •  
  • Chapter 3. Polymerase Chain Reaction Market– Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Polymerase Chain Reaction Market Drivers: Impact Analysis
      • 3.2.2. Increasing Number of Hospitals and Research Center
      • 3.2.3. The rise in Government Funding
    • 3.3. Market Restraints
      • 3.3.1. Global Polymerase Chain Reaction Market Restraints: Impact Analysis
      • 3.3.2. Reimbursement issues
    • 3.4. Opportunities
      • 3.4.1. Increase in Genetic Diseases
    • 3.5. Porter’s Five Forces Analysis
      • 3.5.1. Bargaining Power of Suppliers
      • 3.5.2. Bargaining Power of Buyers
      • 3.5.3. The threat of New Entrants
      • 3.5.4. The threat of New Substitutes
      • 3.5.5. Degree of Competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market Attractiveness Analysis, by Product Segment
      • 3.6.2. Market Attractiveness Analysis, by End-User Segment
      • 3.6.3. Market Attractiveness Analysis, by Regional Segment
  •  
  • Chapter 4. Global Polymerase Chain Reaction Market– Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Polymerase Chain Reaction Market: Company Market Share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapy Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research And Development and Regional Expansion
    • 4.3. Price Trend Analysis
  •  
  • Chapter 5. Global Polymerase Chain Reaction Market– Product Segment Analysis
    • 5.1. Global Polymerase Chain Reaction Market: Product Overview
      • 5.1.1. Global Polymerase Chain Reaction Market Revenue Share, by Product, 2017 and 2023
    • 5.2. Instruments
      • 5.2.1. Global Polymerase Chain Reaction Market for Instruments, 2015 – 2023 (USD Billion)
    • 5.3. Reagents and Consumables
      • 5.3.1. Global Polymerase Chain Reaction Market for Reagents and Consumables, 2015 – 2023 (USD Billion)
    • 5.4. Software
      • 5.4.1. Global Polymerase Chain Reaction Market for Software, 2015 – 2023 (USD Billion)
  •  
  • Chapter 6. Global Polymerase Chain Reaction Market– End-User Segment Analysis
    • 6.1. Global Polymerase Chain Reaction Market: End User Overview
      • 6.1.1. Global Polymerase Chain Reaction Market Revenue Share, by End User, 2017 and 2023
    • 6.2. Pharmaceutical and Biotechnology Industries
      • 6.2.1. Global Polymerase Chain Reaction Market for Pharmaceutical and Biotechnology Industries, 2015 – 2023 (USD Billion)
    • 6.3. Clinical Diagnostics Labs and Hospitals
      • 6.3.1. Global Polymerase Chain Reaction Market for Clinical Diagnostics Labs and Hospitals, 2015 – 2023 (USD Billion)
    • 6.4. Academic and Research Organizations
      • 6.4.1. Global Polymerase Chain Reaction Market for Academic and Research Organizations, 2015 – 2023 (USD Billion)
  •  
  • Chapter 7. Global Polymerase Chain Reaction Market– Regional Segment Analysis
    • 7.1. Global Polymerase Chain Reaction Market: Regional Overview
      • 7.1.1. Global Polymerase Chain Reaction Market Revenue Share, by Region, 2017 And 2023
    • 7.2. North America
      • 7.2.1. North America Polymerase Chain Reaction Market, 2015 – 2023 (USD Billion)
      • 7.2.2. North America Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
      • 7.2.3. North America Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
        • 7.2.4.2. U.S. Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Polymerase Chain Reaction Market, 2015 – 2023 (USD Billion)
      • 7.3.2. Europe Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
      • 7.3.3. Europe Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
      • 7.3.4. UK
        • 7.3.4.1. UK Polymerase Chain Reaction Revenue, by Product, 2015 – 2023 (USD Billion)
        • 7.3.4.2. UK Polymerase Chain Reaction Revenue, by End User, 2015 – 2023 (USD Billion)
        • 7.3.4.3.
      • 7.3.5. Germany
        • 7.3.5.1. Germany Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
        • 7.3.5.2. Germany Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
      • 7.3.6. France
        • 7.3.6.1. France Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
        • 7.3.6.2. France Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Polymerase Chain Reaction Market, 2015 – 2023 (USD Billion)
      • 7.4.2. Asia Pacific Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
      • 7.4.3. Asia Pacific Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
      • 7.4.4. China
        • 7.4.4.1. China Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
        • 7.4.4.2. China Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
        • 7.4.5.2. Japan Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
      • 7.4.6. India
        • 7.4.6.1. India Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
        • 7.4.6.2. India Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Polymerase Chain Reaction Market, 2015 – 2023 (USD Billion)
      • 7.5.2. Latin America Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
      • 7.5.3. Latin America Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
        • 7.5.4.2. Brazil Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa Polymerase Chain Reaction Market, 2015 – 2023 (USD Billion)
      • 7.6.2. Middle East and Africa Polymerase Chain Reaction Market Revenue, by Product, 2015 – 2023 (USD Billion)
      • 7.6.3. Middle East and Africa Polymerase Chain Reaction Market Revenue, by End User, 2015 – 2023 (USD Billion)
  •  
  • Chapter 8. Company Profile
    • 8.1. Affymetrix, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Agilent Technologies, Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Sigma Aldrich Corporation
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Abbott Laboratories
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Beckman Coulter
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Bio-Rad Laboratories
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. GE Healthcare
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. QIAGEN
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Therapy portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Becton Dickinson & Company
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Therapy portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Thermo Fischer
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Therapy portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Polymerase Chain Reaction (PCR)  market. Zion Market Research has collected and analyzed key data belong to the global Polymerase Chain Reaction (PCR)  market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Polymerase Chain Reaction (PCR)  across the world has been calculated through primary and secondary research.

Zion Market Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Market Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Polymerase Chain Reaction (PCR)  industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases, and market reports

News articles, press releases, and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Polymerase Chain Reaction (PCR)  market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split into segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage, and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Polymerase chain reaction (PCR) also known as molecular photocopying is a technique used to amplify the small segments of DNA and RNA strands into billions of copies. It is a technique mainly used in molecular biology, genetic engineering, archeology, and biomedical researchers. In this technique, a polymerase enzyme is used to synthesize the required DNA, with the help of primers, buffer, and nucleotides. PCR is an easy, cheap and reliable way to replicate the focused DNA segment. PCR involves a process of heating and cooling called thermal cycling which is responsible for denaturation, annealing and extending of the DNA strand. Denaturation, annealing, and extension are repeated approximately 20 to 40 times so that the DNA doubles each time and amplified number of DNA strands are obtained.

PCR is mainly used in the mapping technique for the human genome project. The human genome project is an international collaborative research program which was formulated to completely map and understand all the genes of humans. Therefore it is a major driver for the growth of global polymerase chain reaction market. Increase in geriatric population, the high prevalence of disease and disorders like cancer, HIV-AIDS, Ebola, etc., rise in a number of diagnostic centers and hospitals, and technological advancements also drive the polymerase chain reaction technology market.  The increase in demand for research and development has also led to the growth of the global polymerase chain reaction market. PCR is also used to detect pathogenic microbes such as mycobacterium tuberculosis bacteria and influenza viruses. Due to this reason, there is an increase in demand for PCR in hospitals which drives the growth of the global polymerase chain reaction market. However, reimbursement issues and non-validated home-brew test acts as a restraint for the growth of the market. The high cost of machine and reagents also affects the growth of the global polymerase chain reaction market.

Global Polymerase Chain Reaction Market

Based on product, the market is segmented into instruments, reagents and consumables and software. The reagents and consumables segment is expected to exhibit the highest growth in the forecast period.

Based on the end user, the market is segmented into pharmaceutical and biotechnology industry, clinical diagnostics labs and hospitals and academic and research organizations. Clinical diagnostics and hospitals segment is expected to grow at the fastest rate over the forecast period.

North America is projected to continue its supremacy, in global polymerase chain reaction market, in the forthcoming years. The growth of this regional market is due to the increase in the demand for sophisticated diagnostics laboratories.  

Some of the key players in the global Pigments market are Affymetrix, Inc., Agilent Technologies, Inc., Sigma Aldrich Corporation, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, QIAGEN, Becton Dickinson & Company and Thermo Fischer Scientific. Major players are frequently engaged in mergers & acquisitions to retain their market share and diversify their product portfolio.  Currently, the market’s growth rate is very high, which has encouraged the leading players to focus on the development of new processes so that PCR becomes more efficient.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social